Skip to content

Tert-butyl 2-[(2R)-4-[1-(6-cyanopyridazin-4-yl)-4-fluoropyrazol-3-yl]-3-oxomorpholin-2-yl]-2-hydroxypropanoate

C19H21FN6O5 — CID 90328771

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACtert-butyl 2-[(2R)-4-[1-(6-cyanopyridazin-4-yl)-4-fluoropyrazol-3-yl]-3-oxomorpholin-2-yl]-2-hydroxypropanoate
SMILESCC(C)(C)OC(=O)C(C)(O)[C@H]1OCCN(c2nn(-c3cnnc(C#N)c3)cc2F)C1=O
InChIInChI=1S/C19H21FN6O5/c1-18(2,3)31-17(28)19(4,29)14-16(27)25(5-6-30-14)15-13(20)10-26(24-15)12-7-11(8-21)23-22-9-12/h7,9-10,14,29H,5-6H2,1-4H3/t14-,19?/m0/s1
InChIKeyQHEGVIHJQFSEEC-KTQQKIMGSA-N
MW432.41 g/mol
LogP0.50
Rot. Bonds4

About Tert-butyl 2-[(2R)-4-[1-(6-cyanopyridazin-4-yl)-4-fluoropyrazol-3-yl]-3-oxomorpholin-2-yl]-2-hydroxypropanoate

Tert-butyl 2-[(2R)-4-[1-(6-cyanopyridazin-4-yl)-4-fluoropyrazol-3-yl]-3-oxomorpholin-2-yl]-2-hydroxypropanoate (PubChem CID 90328771) has the molecular formula C19H21FN6O5 and a molecular weight of 432.41 g/mol. Its IUPAC name is tert-butyl 2-[(2R)-4-[1-(6-cyanopyridazin-4-yl)-4-fluoropyrazol-3-yl]-3-oxomorpholin-2-yl]-2-hydroxypropanoate.

Molecular Properties

Compound NameTert-butyl 2-[(2R)-4-[1-(6-cyanopyridazin-4-yl)-4-fluoropyrazol-3-yl]-3-oxomorpholin-2-yl]-2-hydroxypropanoate
PubChem CID90328771
Molecular FormulaC19H21FN6O5
Molecular Weight432.41 g/mol
Exact Mass432.16
IUPAC Nametert-butyl 2-[(2R)-4-[1-(6-cyanopyridazin-4-yl)-4-fluoropyrazol-3-yl]-3-oxomorpholin-2-yl]-2-hydroxypropanoate
SMILESCC(C)(C)OC(=O)C(C)(O)[C@H]1OCCN(c2nn(-c3cnnc(C#N)c3)cc2F)C1=O
InChIInChI=1S/C19H21FN6O5/c1-18(2,3)31-17(28)19(4,29)14-16(27)25(5-6-30-14)15-13(20)10-26(24-15)12-7-11(8-21)23-22-9-12/h7,9-10,14,29H,5-6H2,1-4H3/t14-,19?/m0/s1
InChIKeyQHEGVIHJQFSEEC-KTQQKIMGSA-N
XLogP0.50
TPSA143.46 Ų
H-Bond Donors1
H-Bond Acceptors10
Rotatable Bonds4
Heavy Atoms31
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500432.41
LogP ≤ 50.50
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1010

Analyze Tert-butyl 2-[(2R)-4-[1-(6-cyanopyridazin-4-yl)-4-fluoropyrazol-3-yl]-3-oxomorpholin-2-yl]-2-hydroxypropanoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Tert-butyl 2-[(2R)-4-[1-(6-cyanopyridazin-4-yl)-4-fluoropyrazol-3-yl]-3-oxomorpholin-2-yl]-2-hydroxypropanoate?
The IUPAC name of Tert-butyl 2-[(2R)-4-[1-(6-cyanopyridazin-4-yl)-4-fluoropyrazol-3-yl]-3-oxomorpholin-2-yl]-2-hydroxypropanoate (CID 90328771) is tert-butyl 2-[(2R)-4-[1-(6-cyanopyridazin-4-yl)-4-fluoropyrazol-3-yl]-3-oxomorpholin-2-yl]-2-hydroxypropanoate.
What is the SMILES notation for Tert-butyl 2-[(2R)-4-[1-(6-cyanopyridazin-4-yl)-4-fluoropyrazol-3-yl]-3-oxomorpholin-2-yl]-2-hydroxypropanoate?
The canonical SMILES for Tert-butyl 2-[(2R)-4-[1-(6-cyanopyridazin-4-yl)-4-fluoropyrazol-3-yl]-3-oxomorpholin-2-yl]-2-hydroxypropanoate is CC(C)(C)OC(=O)C(C)(O)[C@H]1OCCN(c2nn(-c3cnnc(C#N)c3)cc2F)C1=O.
What is the InChIKey of Tert-butyl 2-[(2R)-4-[1-(6-cyanopyridazin-4-yl)-4-fluoropyrazol-3-yl]-3-oxomorpholin-2-yl]-2-hydroxypropanoate?
The InChIKey is QHEGVIHJQFSEEC-KTQQKIMGSA-N. The full InChI is InChI=1S/C19H21FN6O5/c1-18(2,3)31-17(28)19(4,29)14-16(27)25(5-6-30-14)15-13(20)10-26(24-15)12-7-11(8-21)23-22-9-12/h7,9-10,14,29H,5-6H2,1-4H3/t14-,19?/m0/s1.
What are the key properties of Tert-butyl 2-[(2R)-4-[1-(6-cyanopyridazin-4-yl)-4-fluoropyrazol-3-yl]-3-oxomorpholin-2-yl]-2-hydroxypropanoate?
Tert-butyl 2-[(2R)-4-[1-(6-cyanopyridazin-4-yl)-4-fluoropyrazol-3-yl]-3-oxomorpholin-2-yl]-2-hydroxypropanoate has a molecular weight of 432.41 g/mol, XLogP of 0.50, 4 rotatable bonds, 1 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for Tert-butyl 2-[(2R)-4-[1-(6-cyanopyridazin-4-yl)-4-fluoropyrazol-3-yl]-3-oxomorpholin-2-yl]-2-hydroxypropanoate is sourced from PubChem (CID 90328771), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.